Roopa Industries Ltd vs Torrent Pharmaceuticals Ltd

A side-by-side comparison of Roopa Industries Ltd (530991) and Torrent Pharmaceuticals Ltd (TORNTPHARM) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Torrent Pharmaceuticals Ltd leads 530991 vs TORNTPHARM on 12 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

452.30
P/E ratio
80.14
2.22
P/B ratio
18.67
0.00%
Dividend yield
0.78%
₹2.58
EPS
₹63.92

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

23.20%
Return on equity
27.40%
12.00%
Return on capital
15.00%
3.00%
EBITDA margin
33.00%
1.65%
Net margin
15.29%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

18.82%
Revenue CAGR (3Y)
13.27%
-60.85%
Profit CAGR (3Y)
19.75%

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹39 Cr
Market cap
₹1.94L Cr
₹121 Cr
Revenue
₹13,980 Cr
₹2 Cr
Net profit
₹2,138 Cr
1.72
Debt / equity
1.69
Roopa Industries Ltd
  • ["Though the company is reporting repeated profits, it is not paying out dividend", "Debtor days have increased from 48.4 to 62.8 days."]
Torrent Pharmaceuticals Ltd
  • + ["Company is expected to give good quarter", "Company has a good return on equity (ROE) track record: 3 Years ROE 26.2%", "Company has been maintaining a healthy dividend payout of 57.8%"]
  • ["Stock is trading at 20.7 times its book value", "Promoter holding has decreased over last quarter: -7.53%", "The company has delivered a poor sales growth of 11.8% over past five years.", "Company might be capitalizing the interest cost"]
Roopa Industries Ltd full analysis Torrent Pharmaceuticals Ltd full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.